Lipocine Presents Phase 3 Data for LPCN 1154 (Oral Brexanolone) for Postpartum Depression at ASCP

Lipocine Inc.

May 26, 2026: Company highlighted results from placebo-controlled Phase 3 trial of LPCN 1154 for PPD at ASCP Annual Meeting.
The presentation and poster are furnished as exhibits but not included in the 8-K text; specific efficacy and safety endpoints are unconfirmed.
LPCN 1154 is an oral rapid-acting neuroactive steroid (brexanolone); this readout supports potential label expansion.
Stock impact uncertain without actual data; materiality depends on trial outcomes not disclosed in this filing.

item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001493152-26-025270
form_type: 8-K
ticker: LPCN
cik: 0001535955
company_name: Lipocine Inc.
filed_at: 2026-05-26T21:08:04+00:00
discovered_at: 2026-05-26T21:10:00.282009+00:00
generated_at: 2026-05-26T21:17:07.073628+00:00
sec_items: ["8.01", "9.01"]
event_type: other
sentiment: neutral
materiality_score: 0.75
confidence: low
secwatch_canonical_url: https://secwatch.observer/filing/0001493152-26-025270
json_url: https://secwatch.observer/filing/0001493152-26-025270.json
markdown_url: https://secwatch.observer/filing/0001493152-26-025270.md
text_url: https://secwatch.observer/filing/0001493152-26-025270.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1535955/000149315226025270/0001493152-26-025270-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1535955/000149315226025270/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001493152-26-025270

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.